Home > Boards > US Listed > Telecommunications Hardware > Terayon Communication Systems (TERN)

Terayon share price skyrockets on acquisition rumors

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
midastouch017 Member Profile
 
Followed By 128
Posts 26,174
Boards Moderated 4
Alias Born 02/07/04
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2022 4:11:00 PM
Terns Pharmaceuticals Appoints Jeffrey R. Jasper, Ph.D., as Senior Vice President, Head of Research and Promotes Diana Chung to Senior Vice President, Chief Development Officer GlobeNewswire Inc. - 1/6/2022 7:05:00 AM
Terns Pharmaceuticals to Present at 40th Annual J.P. Morgan Health Care Conference GlobeNewswire Inc. - 1/3/2022 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 4:58:55 PM
Terns Pharmaceuticals EPS beats by $0.13 Seeking Alpha - 11/15/2021 4:53:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 4:38:18 PM
Terns Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights GlobeNewswire Inc. - 11/15/2021 4:05:00 PM
Terns Pharmaceuticals Highlights Positive Clinical Data from Multiple NASH Programs at AASLD The Liver Meeting® Digital Experience 2021 GlobeNewswire Inc. - 11/12/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:55:02 PM
Terns Reports Positive Top-line Results from Phase 1 Proof of Concept Clinical Trial of THR-β agonist TERN-501 GlobeNewswire Inc. - 11/9/2021 4:05:00 PM
Terns Pharmaceuticals to Present Positive Clinical Data on NASH Programs at AASLD The Liver Meeting® Digital Experience 2021 GlobeNewswire Inc. - 10/18/2021 4:05:00 PM
Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference GlobeNewswire Inc. - 10/5/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2021 6:03:47 AM
Terns Appoints Veteran Biopharmaceutical Executive Ann E. Taylor, M.D. to Board of Directors GlobeNewswire Inc. - 9/28/2021 4:05:00 PM
Goldman Sachs Sees These 2 Stocks Surging Over 70% TipRanks - 9/15/2021 6:07:42 PM
Terns Completes Part 1 Enrollment of AVIATION Phase 1b NASH Clinical Trial of VAP-1 Inhibitor TERN-201 GlobeNewswire Inc. - 9/8/2021 7:05:00 AM
Terns Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 9/2/2021 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:44:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 4:26:04 PM
Terns Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights GlobeNewswire Inc. - 8/16/2021 4:05:00 PM
Terns Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 8/3/2021 4:05:00 PM
Terns Pharmaceuticals doses first patient in early-stage TERN-201 NASH study Seeking Alpha - 6/24/2021 4:11:37 PM
Terns Announces Initiation of Patient Dosing in AVIATION Phase 1b NASH Clinical Trial of VAP-1 Inhibitor TERN-201 GlobeNewswire Inc. - 6/24/2021 4:05:00 PM
Terns Pharmaceuticals up 9% on positive phase 2 NASH data Seeking Alpha - 6/14/2021 8:42:34 AM
Terns Pharma gains 9% on positive TERN-101 data in mid-stage NASH study Seeking Alpha - 6/14/2021 8:12:23 AM
midastouch017   Sunday, 02/18/07 04:21:07 PM
Re: SEBASS post# 321
Post # of 329 
Terayon share price skyrockets on acquisition rumors
“Light Reading” cites industry sources as saying, “The winner could pay as much as $250 million for Terayon, at up to $3 per share.”
Shiri Habib 18 Feb 07 15:57
Terayon Communication Systems Inc. (Pink Sheets: TERN.PK) rose 16% on Friday on rumors of a pending takeover. “Light Reading” reported, “Motorola Inc. (NYSE: MOT) is generally considered the favorite to win the prize” in a three-way race with Cisco Systems Inc. (Nasdaq: CSCO) and Harmonic Inc. (Nasdaq: HLIT).
“Light Reading” said that Terayon declined to comment on reports of a pending takeover.

Terayon, a developer of broadband access solutions for homes and digital video applications, was founded by chairman Zaki Rakib and his brother, Shlomo, a company director, in 1993. Both men still own shares in the company.

“Light Reading” cites industry sources as saying, “The winner could pay as much as $250 million for Terayon, based on a valuation of up to $3 per outstanding share. That price could conceivably go even higher if a new bidding war erupts and the suitors decide to up the ante.”

Terayon is currently traded at $2.10 per share, which means a takeover is being suggested at a premium of 44% of the company’s market price.

“Light Reading” adds, “A fourth would-be suitor, Arris Group Inc. (Nasdaq: ARRS), has dropped out of the Terayon bidding contest after snatching a much larger catch, Tandberg Television ASA (OFX:TAT), from the clutches of such rivals as Motorola… for $1.2 billion.”

Tandberg is a rival of Israeli companies Optibase Ltd. (Nasdaq: OBAS) and Scopus Video Networks Ltd. (Nasdaq:SCOP).

Published by Globes [online], Israel business news - www.globes.co.il - on February 18, 2007

http://www.globes.co.il/serveen/globes/DocView.asp?did=1000184092


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences